Service Overview

End-to-End Value Proposition

Cheerland CDMO Services

Cheerland strives to provide global clients with clinical development and commercial supply of biosimilars and innovative biologics.

  • End-to-end value proposition ranging from DNA to IND to commercial manufacturing;
  • State-of-the-art facility with scientific expertise to deliver high-quality, cost-effective and fast-to-market products;
  • Highly experienced international team;
  • Flexible business models;
  • Global regulatory support.
biologics CDMO

(click image to see details)